Your patient is exploring osteogenic loading with us. This isn't a gym, a supplement, or a treatment — it's a supervised, evidence-based way to load the skeleton and trigger the body's own bone-building response. Here's the clinical picture in under three minutes: the mechanism, the safety profile, who it fits, and what we measure.
OsteoStrong uses a four-device circuit that lets your patient self-generate axial compressive force at multiples of body weight in a controlled, supervised range. This emulates the high-impact loading that builds bone — without the impact or injury risk. The stimulus drives mechanotransduction: the osteocyte-mediated signaling by which mechanical strain triggers osteogenesis. Loading is isometric and self-limited; the patient controls the force against a fixed device, with real-time biofeedback in pounds and multiples of body weight.
Bisphosphonates are often the first line for osteoporosis, but tolerance and long-term concerns complicate that decision for many patients. OsteoStrong is designed to complement pharmacotherapy or serve as a non-pharmacologic option — not replace physician-directed care.
It gives patients who can't or won't take medication a supervised, measurable path, and gives medicated patients an additional loading stimulus.
Because force is self-generated and isometric, the ceiling is set by the patient, not the machine — which is why this is appropriate even for higher-risk patients. No exercise is entirely without risk. We request physician clearance before starting when a patient has any of the following, and we defer entirely to your judgment and any restrictions you specify: recent fracture, active spinal pathology, uncontrolled hypertension or cardiovascular disease, retinal conditions, pregnancy, or recent surgery.
We offer in-center REMS (Radiofrequency Echographic Multi Spectrometry) — a radiation-free ultrasound assessment of bone density and quality — to set a baseline and track change. It complements, and does not replace, DXA. Your patient can share every result with your office.
OsteoStrong members have reported BMD increases of up to 14% over 12 months between DXA scans, alongside:
At our center, members have measured gains on their own physician-ordered follow-up scans. Individual results vary.
The approach is backed by peer-reviewed studies — including 2025 postmenopausal osteoporosis trials, the Karolinska BONEMORE study, and UK Biobank data on high-intensity loading and bone health. Review the full library:
Read the Research at OsteoStrong.me →If you're comfortable, a brief note stating your patient is cleared for supervised, controlled resistance loading — with any restrictions you want observed — is all we need to begin. We're glad to coordinate directly with your office, and you're welcome to experience a session yourself so you can advise from firsthand knowledge.